Vaccines, blood, antisera, toxins and cultures in   Gambia

Exports In 2023, Gambia exported $50.5M in Vaccines, blood, antisera, toxins and cultures, making it the 53rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 10th most exported product in Gambia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Gambia are: Kazakhstan ($50.5M), India ($2.32k), South Africa ($49), Indonesia ($40), and Belgium ($24).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Gambia between 2022 and 2023 were Kazakhstan ($50.5M), India ($2.32k), and Indonesia ($40).

Imports In 2023, Gambia imported $8.89M in Vaccines, blood, antisera, toxins and cultures, becoming the 157th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 45th most imported product in Gambia. Gambia imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($7.81M), India ($807k), Netherlands ($160k), China ($32.7k), and Bulgaria ($20.3k).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Gambia between 2022 and 2023 were Belgium ($3.23M), Netherlands ($132k), and India ($26.9k).